Balance Sheet
Cash Flow Statement
AmortizationBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Net Cash Flow (2024 - 2025)

Historic Net Cash Flow for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to $626.0 million.

  • Abivax's Net Cash Flow rose 152770.07% to $626.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $495.0 million, marking a year-over-year increase of 73650.25%. This contributed to the annual value of -$117.7 million for FY2024, which is 14727.68% down from last year.
  • Latest data reveals that Abivax reported Net Cash Flow of $626.0 million as of Q3 2025, which was up 152770.07% from -$47.5 million recorded in Q2 2025.
  • In the past 5 years, Abivax's Net Cash Flow ranged from a high of $626.0 million in Q3 2025 and a low of -$47.5 million during Q2 2025